We are live on ! Find out more
P8IP

Pier 88 Investment Partners Portfolio holdings

AUM $421M
1-Year Est. Return 14.71%
This Fund
S&P 500
This Quarter Est. Return
-2.06%
1 Year Est. Return
+14.71%
3 Year Est. Return
+36.1%
5 Year Est. Return
+43.13%
10 Year Est. Return
AUM
$521M
AUM Growth
+$13.1M
Cap. Flow
-$292M
Cap. Flow %
-56.03%
Top 10 Hldgs %
44.91%
Holding
111
New
14
Increased
34
Reduced
29
Closed
7

Sector Composition

Rank Sector Weight
1 Technology 6.72%
2 Healthcare 3.05%
3 Consumer Discretionary 2.51%
4 Industrials 1.5%
5 Financials 1.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FPI
51
Farmland Partners
FPI
$425M
$706K 0.14%
63,340
-1,190
-2% -$13.7K
RVLV icon
52
Revolve Group
RVLV
$1.69B
$704K 0.14%
32,780
+16,740
+104% +$465K
ITT icon
53
ITT
ITT
$19.4B
$692K 0.13%
5,360
-21,380
-80% -$3.05M
CFLT
54
DELISTED
Confluent
CFLT
$682K 0.13%
+29,090
New +$842K
FRSH icon
55
Freshworks
FRSH
$3.31B
$675K 0.13%
+47,850
New +$801K
COHR icon
56
Coherent
COHR
$64.3B
$638K 0.12%
9,820
+4,280
+77% +$355K
ATI icon
57
ATI
ATI
$31.3B
$634K 0.12%
12,182
+4,562
+60% +$259K
PRO
58
DELISTED
PROS Holdings
PRO
$630K 0.12%
33,100
-45,790
-58% -$1.07M
ANET icon
59
Arista Networks
ANET
$250B
$617K 0.12%
7,960
+120
+2% +$12.2K
DNLI icon
60
Denali Therapeutics
DNLI
$3.95B
$611K 0.12%
44,910
-500
-1% -$9.58K
HUBS icon
61
HubSpot
HUBS
$11B
$588K 0.11%
1,030
-1,290
-56% -$905K
GTLS
62
DELISTED
Chart Industries
GTLS
$559K 0.11%
3,870
-1,920
-33% -$354K
ABCL icon
63
AbCellera Biologics
ABCL
$2.99B
$544K 0.1%
243,790
+6,890
+3% +$19.8K
DDOG icon
64
Datadog
DDOG
$88.6B
$519K 0.1%
5,230
-3,670
-41% -$463K
HALO icon
65
Halozyme
HALO
$11.6B
$507K 0.1%
+7,950
New +$462K
RXRX icon
66
Recursion Pharmaceuticals
RXRX
$1.8B
$501K 0.1%
94,790
-66,940
-41% -$488K
ALAB icon
67
Astera Labs
ALAB
$54.1B
$493K 0.09%
+8,260
New +$764K
PRCT icon
68
Procept Biorobotics
PRCT
$1.31B
$433K 0.08%
7,430
-2,000
-21% -$137K
IOVA icon
69
Iovance Biotherapeutics
IOVA
$2.94B
$423K 0.08%
126,940
+72,310
+132% +$373K
DTE icon
70
DTE Energy
DTE
$28.6B
$400K 0.08%
2,894
PYXS icon
71
Pyxis Oncology
PYXS
$179M
$383K 0.07%
390,960
+292,370
+297% +$390K
RCKT icon
72
Rocket Pharmaceuticals
RCKT
$384M
$379K 0.07%
56,820
+19,320
+52% +$191K
KEYS icon
73
Keysight
KEYS
$58.7B
$377K 0.07%
2,515
-400
-14% -$66K
D icon
74
Dominion Energy
D
$59.9B
$242K 0.05%
4,315
DXCM icon
75
DexCom
DXCM
$33.8B
$223K 0.04%
3,260
-3,140
-49% -$256K

Similar funds

Pier 88 Investment Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Pier 88 Investment Partners held 111 positions worth $521M, up 2.6% from $508M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Pier 88 Investment Partners withdrew a net $292M in Q1 2025, closing 7 positions and reducing 29 holdings. Its most notable exit was Alphabet (Google) Class A, an estimated $3.07M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.7% of assets, up from 6.3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Pier 88 Investment Partners opened a new position in NextEra Energy 7.234% Corporate Units worth $16.5M.

  • Pier 88 Investment Partners's largest Q1 2025 buy was NextEra Energy 7.234% Corporate Units: 363,240 shares worth $16.5M.
  • Pier 88 Investment Partners added most to Okta in Q1 2025, an estimated $3.24M increase.
  • Pier 88 Investment Partners's biggest Q1 2025 reduction was Hewlett Packard Enterprise 7.625% Series C Preferred Stock, cutting an estimated $7.01M.
  • Pier 88 Investment Partners fully exited Alphabet (Google) Class A in Q1 2025, selling an estimated $3.07M.
  • Pier 88 Investment Partners's ten largest holdings make up 45% of its $521M portfolio in Q1 2025.
  • Pier 88 Investment Partners opened 14 new positions and closed 7 in Q1 2025.
  • Pier 88 Investment Partners's portfolio value rose 2.6% quarter-over-quarter to $521M.

Based on Pier 88 Investment Partners's 13F filing for Q1 2025, filed 6 May 2025.